Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

ProQR Therapeutics N.V. sell StockNews.com

Start price
€1.81
11.05.24 / 50%
Target price
-
11.05.25
Performance (%)
-2.38%
Price
€1.74
24.05.24
Summary
This prediction is currently active. With a performance of -2.38%, the SELL prediction for ProQR Therapeutics N.V. by StockNews_com is down slightly. This prediction currently runs until 11.05.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this prediction
Performance without dividends (%)
Name 1w
ProQR Therapeutics N.V. -2.360%
iShares Core DAX® -0.205%
iShares Nasdaq 100 1.613%
iShares Nikkei 225® -0.740%
iShares S&P 500 0.267%

Comments by StockNews_com for this prediction

In the thread ProQR Therapeutics N.V. diskutieren

ProQR Therapeutics (NASDAQ: PRQR) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for PRQR provided by MarketBeat

Stopped prediction by StockNews_com for ProQR Therapeutics N.V.

buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.81
12.03.24
-
12.03.25
-6.84%
24.05.24

buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.25
11.11.23
-
11.11.24
40.96%
24.05.24